{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T02:42:24Z","timestamp":1776825744131,"version":"3.51.2"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,10,29]],"date-time":"2011-10-29T00:00:00Z","timestamp":1319846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s00228-011-1144-y","type":"journal-article","created":{"date-parts":[[2011,10,28]],"date-time":"2011-10-28T15:09:01Z","timestamp":1319814541000},"page":"435-439","source":"Crossref","is-referenced-by-count":38,"title":["Risk of caffeine toxicity associated with the use of \u2018legal highs\u2019 (novel psychoactive substances)"],"prefix":"10.1007","volume":"68","author":[{"given":"Susannah","family":"Davies","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul I.","family":"Dargan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,10,29]]},"reference":[{"key":"1144_CR1","unstructured":"EMCDDA (2010) EMCDDA\u2013Europol 2010 annual report on the implementation of Council Decision 2005\/387\/JHA. http:\/\/www.emcdda.europa.eu\/attachements.cfm\/att_132857_EN_EMCDDA-Europol%20Annual%20Report%202010A.pdf . Accessed 11 Aug 2011"},{"key":"1144_CR2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3109\/10826080903443628","volume":"45","author":"J Hillebrand","year":"2010","unstructured":"Hillebrand J, Olszewski D, Sedefov R (2010) Legal highs on the Internet. Subst Use Misuse 45:330\u2013340","journal-title":"Subst Use Misuse"},{"key":"1144_CR3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/dta.312","volume":"3","author":"PI Dargan","year":"2011","unstructured":"Dargan PI, Sedefov R, Gallegos A, Wood DM (2011) The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone). Drug Test Anal 3:454\u2013463","journal-title":"Drug Test Anal"},{"key":"1144_CR4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF03161195","volume":"4","author":"S Lidder","year":"2008","unstructured":"Lidder S, Dargan PI, Sexton M, Button J, Ramsey J, Holt DW, Wood DM (2008) Cardiovascular toxicity associated with recreational use of diphenylprolinol (diphenyl-2-pyrrolidinemethanol (D2PM)). J Med Toxicol 4:167\u2013169","journal-title":"J Med Toxicol"},{"key":"1144_CR5","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0140-6736(07)60674-6","volume":"369","author":"DM Wood","year":"2007","unstructured":"Wood DM, Dargan PI, Button J, Holt DW, Ovaska H, Ramsey J, Jones AL (2007) Collapse, reported seizure\u2014and an unexpected pill. Lancet 369:1490","journal-title":"Lancet"},{"key":"1144_CR6","first-page":"223","volume":"9","author":"DM Wood","year":"2008","unstructured":"Wood DM, Ramsey J, Dargan PI (2008) Detecting novel and emerging recreational drugs on the \u2018club scene\u2019. Irish Psychiatrist 9:223\u2013228","journal-title":"Irish Psychiatrist"},{"key":"1144_CR7","doi-asserted-by":"crossref","first-page":"c3564","DOI":"10.1136\/bmj.c3564","volume":"341","author":"SD Brandt","year":"2010","unstructured":"Brandt SD, Sumnall HR, Measham F, Cole J (2010) Second generation mephedrone. The confusing case of NRG-1. BMJ 341:c3564","journal-title":"BMJ"},{"key":"1144_CR8","doi-asserted-by":"crossref","unstructured":"Brandt SD, Freeman S, Sumnall HR, Measham F, Cole J (2011) Analysis of NRG \u2018legal highs\u2019 in the UK: identification and formation of novel cathinones. Drug Test Anal. doi: 10.1002\/dta.204","DOI":"10.1002\/dta.204"},{"key":"1144_CR9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/qjmed\/hcq132","volume":"103","author":"J Ramsey","year":"2010","unstructured":"Ramsey J, Dargan PI, Smyllie M, Davies S, Button J, Holt DW, Wood DM (2010) Buying \u2018legal\u2019 recreational drugs does not mean that you are not breaking the law. QJM 103:777\u2013783","journal-title":"QJM"},{"key":"1144_CR10","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/qjmed\/hcq056","volume":"103","author":"S Davies","year":"2010","unstructured":"Davies S, Wood DM, Smith G, Button J, Ramsey J, Archer R, Holt DW, Dargan PI (2010) Purchasing \u2018legal highs\u2019 on the Internet\u2013is there consistency in what you get? QJM 103:489\u2013493","journal-title":"QJM"},{"key":"1144_CR11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5694\/j.1326-5377.2009.tb02263.x","volume":"190","author":"AJ Berger","year":"2009","unstructured":"Berger AJ, Alford K (2009) Cardiac arrest in a young man following excess consumption of caffeinated \"energy drinks\". Med J Aust 190:41\u201343","journal-title":"Med J Aust"},{"key":"1144_CR12","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1542\/peds.2009-3592","volume":"127","author":"SM Seifert","year":"2011","unstructured":"Seifert SM, Schaechter JL, Hershorin ER, Lipshultz SE (2011) Health effects of energy drinks on children, adolescents, and young adults. Pediatrics 127:511\u2013528","journal-title":"Pediatrics"},{"key":"1144_CR13","doi-asserted-by":"crossref","unstructured":"Trabulo D, Marques S, Pedroso E (2011) Caffeinated energy drink intoxication. BMJ Case Rep. doi: 10.1136\/bcr.09.2010.3322","DOI":"10.1136\/bcr.09.2010.3322"},{"issue":"3","key":"1144_CR14","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1331\/JAPhA.2008.07055","volume":"48","author":"KA Clauson","year":"2008","unstructured":"Clauson KA, Shields KM, McQueen CE, Persad N (2008) Safety issues associated with commercially available energy drinks. J Am Pharm Assoc 48(3):e55\u2013e63","journal-title":"J Am Pharm Assoc"},{"key":"1144_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2008.08.001","volume":"99","author":"CJ Reissig","year":"2009","unstructured":"Reissig CJ, Strain EC, Griffiths RR (2009) Caffeinated energy drinks\u2014a growing problem. Drug Alcohol Depend 99:1\u201310","journal-title":"Drug Alcohol Depend"},{"key":"1144_CR16","unstructured":"US Dept of Health and Human Services (2010) FDA Warning Letters issued to four makers of caffeinated alcoholic beverages. http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm234109.htm . Accessed 11 Aug 2011"},{"key":"1144_CR17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/dta.220","volume":"3","author":"C Cole","year":"2011","unstructured":"Cole C, Jones L, McVeigh J, Kicman A, Syed Q, Bellis M (2011) Adulterants in illicit drugs: a review of empirical evidence. Drug Test Anal 3:89\u201396","journal-title":"Drug Test Anal"},{"key":"1144_CR18","doi-asserted-by":"crossref","first-page":"468","DOI":"10.7326\/0003-4819-105-3-468_1","volume":"105","author":"AP Passmore","year":"1986","unstructured":"Passmore AP, Kondowe GB, Johnston GD (1986) Caffeine and hypokalemia. Ann Intern Med 105:468","journal-title":"Ann Intern Med"},{"key":"1144_CR19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJM199808133390707","volume":"339","author":"FJ Gennari","year":"1998","unstructured":"Gennari FJ (1998) Hypokalemia. N Engl J Med 339:451\u2013458","journal-title":"N Engl J Med"},{"key":"1144_CR20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1152\/physrev.1992.72.1.101","volume":"72","author":"RJ Huxtable","year":"1992","unstructured":"Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72:101\u2013163","journal-title":"Physiol Rev"},{"key":"1144_CR21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0091-7435(89)90056-X","volume":"18","author":"BS Kendler","year":"1989","unstructured":"Kendler BS (1989) Taurine: an overview of its role in preventive medicine. Prev Med 18:79\u2013100","journal-title":"Prev Med"},{"key":"1144_CR22","unstructured":"European Commission (1999) Opinion on caffeine, taurine and D-glucurono-\u03b3-lactone as constituents of so-called \"energy\" drinks. http:\/\/ec.europa.eu\/food\/fs\/sc\/scf\/out22_en.html . Accessed 11 Aug 2011"},{"key":"1144_CR23","unstructured":"Food Standards Agency (1998) Joint Food Safety Standards Group food surveillance information sheet number 144. Survey of caffeine and other methylxanthines in energy drinks and other caffeine-containing products (updated). http:\/\/archive.food.gov.uk\/maff\/archive\/food\/infsheet\/1998\/no144\/144caff.htm . Accessed 11 Aug 2011"},{"key":"1144_CR24","first-page":"228","volume":"39","author":"S Shum","year":"1997","unstructured":"Shum S, Seale C, Hathaway D, Chucovich V, Beard D (1997) Acute caffeine ingestion fatalities: management issues. Vet Hum Toxicol 39:228\u2013230","journal-title":"Vet Hum Toxicol"},{"key":"1144_CR25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/15563658809167105","volume":"26","author":"CL Leson","year":"1988","unstructured":"Leson CL, McGuigan MA, Bryson SM (1988) Caffeine over-dose in an adolescent male. J Toxicol Clin Toxicol 26:407\u2013415","journal-title":"J Toxicol Clin Toxicol"},{"key":"1144_CR26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1345\/aph.1A161","volume":"36","author":"AA Fisher","year":"2002","unstructured":"Fisher AA, Davis MW (2002) Serotonin syndrome caused by selective serotonin reuptake-inhibitors-metoclopramide interaction. Ann Pharmacother 36:67\u201371","journal-title":"Ann Pharmacother"},{"key":"1144_CR27","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","volume":"352","author":"EW Boyer","year":"2005","unstructured":"Boyer EW, Shannon M (2005) The serotonin syndrome. N Engl J Med 352:1112\u20131120","journal-title":"N Engl J Med"},{"key":"1144_CR28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1258\/rsmsmj.54.4.3","volume":"54","author":"WS Waring","year":"2009","unstructured":"Waring WS, Laing WJ, Good AM, Malkowska AM (2009) Acute caffeine ingestion: clinical features in patients attending the emergency department and Scottish poison centre enquiries between 2000 and 2008. Scott Med J 54:3\u20136","journal-title":"Scott Med J"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-011-1144-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-011-1144-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-011-1144-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T17:58:00Z","timestamp":1593194280000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-011-1144-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,29]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["1144"],"URL":"https:\/\/doi.org\/10.1007\/s00228-011-1144-y","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,29]]}}}